The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients

A novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) causing lethal acute respiratory disease emerged in December 2019. The World Health Organization named this disease “COVID-19” and declared it a pandemic on March 11, 2020. Many studies have shown that mesenchymal stem cells (MSCs) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzahrani, Faisal A., Saadeldin, Islam M., Ahmad, Abrar, Kumar, Dipak, Azhar, Esam I., Siddiqui, Arif Jamal, Kurdi, Bassem, Sajini, Abdulrahim, Alrefaei, Abdulmajeed F., Jahan, Sadaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512102/
https://www.ncbi.nlm.nih.gov/pubmed/33014070
http://dx.doi.org/10.1155/2020/8835986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512102/
https://www.ncbi.nlm.nih.gov/pubmed/33014070
http://dx.doi.org/10.1155/2020/8835986

Ejemplares similares